Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 4, 2008, Pages 766-770

  Treyer, Valerie ^a   Streffer, Johannes ^b   Ametamey, Simon M ^c   Bettio, Andrea ^c   Bläuenstein, Peter ^c   Schmidt, Mark ^d   Gasparini, Fabrizio ^d   Fischer, Uta ^b   Hock, Christoph ^b   Buck, Alfred ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c ETH Zurich   (Switzerland)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

11C ABP688; Dosimetry; Metabotropic glutamate receptor subtype 5; Whole body PET CT

Indexed keywords

ABP 688; CARBON 11; LIGAND; METABOTROPIC RECEPTOR 5; METHYL IODIDE; RADIOLIGAND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DOSE RESPONSE; DOSIMETRY; DRUG DISTRIBUTION; DRUG UPTAKE; GALLBLADDER; HEPATOBILIARY SYSTEM; HUMAN; HUMAN EXPERIMENT; KIDNEY; LIGAND BINDING; LIVER; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RECEPTOR BINDING; RECEPTOR DENSITY; URINARY TRACT; WHOLE BODY AUTORADIOGRAPHY;

BRAIN; CARBON RADIOISOTOPES; HUMANS; KINETICS; OXIMES; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RADIATION DOSAGE; RECEPTORS, METABOTROPIC GLUTAMATE; REFERENCE VALUES; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED; WHOLE-BODY IRRADIATION;

EID: 40949123914     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0638-4     Document Type: Article

References (16)

1. Masu M, Tanabe Y, Tsuchida K, Shigemoto R, Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. Nature 1991;349(6312):760-5.
2. Gasparini F, Lingenhohl K, Stoehr N, Flor PJ, Heinrich M, Vranesic I, et al. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 1999;38(10):1493-503.
3. Kuhn R, Pagano A, Stoehr N, Vranesic I, Flor PJ, Lingenhohl K, et al. In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article. Amino Acids 2002;23(1-3):207-11.
4. Spooren W, Gasparini F. mGlu5 receptor antagonists: a novel class of anxiolytics? Drug News Perspect 2004;17:251-7.
5. Spooren WP, Vassout A, Neijt HC, Kuhn R, Gasparini F, Roux S, et al. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Ther 2000;295(3):1267-75.
6. Tatarczynska E, Klodzinska A, Chojnacka-Wojcik E, Palucha A, Gasparini F, Kuhn R, et al. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol 2001;132(7):1423-30.
7. Hamill TG, Krause S, Ryan C, Bonnefous C, Govek S, Seiders TJ, et al. Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers. Synapse 2005;56(4):205-16.
8. Ametamey SM, Kessler LJ, Honer M, Wyss MT, Hintermann S, Auberson YP, et al. Radiosynthesis and preclinical evaluation of [11C]-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5 (mGluR5). J Nucl Med 2005;47:698-705.
9. Stabin MG. Mirdose: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996;37(3):538-46.
10. Stabin MG, Sparks RB, Crowe E. Olinda/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005;46(6):1023-7.
11. Ametamey SM, Treyer V, Streffer J, Wyss MT, Schmidt M, Blagoev M, et al. Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688. J Nucl Med 2007;48(2):247-52.
12. Ribeiro MJ, Ricard M, Bourgeois S, Lievre MA, Bottlaender M, Gervais P, et al. Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers. Eur J Nucl Med Mol Imaging 2005;32(8):952-8.
13. Bottlaender M, Valette H, Roumenov D, Dolle F, Coulon C, Ottaviani M, et al. Biodistribution and radiation dosimetry of 18F-fluoro-A-85380 in healthy volunteers. J Nucl Med 2003;44(4):596-601.
14. Obrzut SL, Koren AO, Mandelkern MA, Brody AL, Hoh CK, London ED. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies. Nucl Med Biol 2005;32(8):869-74.
15. Seneca N, Andree B, Sjoholm N, Schou M, Pauli S, Mozley PD, et al. Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primates. Nucl Med Commun 2005;26(8):695-700.
16. Slifstein M, Hwang DR, Martinez D, Ekelund J, Huang Y, Hackett E, et al. Biodistribution and Radiation dosimetry of the dopamine D2 Ligand 11C-raclopride determined from human whole-body PET. J Nucl Med 2006;47(2):313-9.